Navigation Links
Disrupting common parasites' ability to 'talk' to each other reduces infection
Date:1/9/2008

St. Louis, Jan. 9, 2007 One of the most common human parasites, Toxoplasma gondii, uses a hormone lifted from the plant world to decide when to increase its numbers and when to remain dormant, researchers at Washington University School of Medicine in St. Louis have found.

The scientists report this week in Nature that they successfully blocked production of the molecule, known as abscisic acid (ABA), with a plant herbicide. Low doses of the herbicide prevented fatal T. gondii infection in mice.

"As a target for drug development, this pathway is very attractive for several reasons," says author L. David Sibley, Ph.D., professor of molecular microbiology. "For example, because of its many roles in plant biology, we already have several inhibitors for it. Also, the plant-like nature of the target decreases the chances that blocking it with a drug will have significant negative side effects in human patients."

T. gondii's relatives include the parasites that cause malaria, which also appear to have genes for ABA synthesis. The new findings may explain an earlier study where a group of researchers found that the same herbicide inhibits malaria.

Infection with T. gondii, or toxoplasmosis, is perhaps most familiar to the general public from the recommendation that pregnant women avoid changing cat litter. Cats are commonly infected with the parasite, as are some livestock and wildlife. Humans can also become infected by eating undercooked meat or by drinking water contaminated with spores shed by cats.

Epidemiologists estimate that as many as one in every four humans is infected with T. gondii. Infections are typically asymptomatic, only causing serious disease in patients with weakened immune systems. In some rare cases, though, infection in patients with healthy immune systems leads to serious eye or central nervous system disease, or congenital defects in the fetuses of pregnant women.

Scientists have known for approximately a decade that protozoan parasites like T. gondii and those that cause malaria contain many plant-like pathways, or groups of genes or proteins put to use for a particular biological task. The common ancestor of these parasites incorporated an algal cell millions of years ago. This endosymbiotic relationship results in the incorporated organism becoming a regular part of the larger organism's cell structure. The parasites can make use of the algae's genes, many of which were transferred to the parasite's nucleus to control processes in a structure that is a remnant of the original algal cells.

That earlier revelation led to ongoing efforts to develop drugs that block plant-like proteins parasites use to synthesize metabolically important structures or compounds. However, until this study, no one had found the parasites using a plant-like protein for signaling purposes.

"Signals are sometimes even better targets for drug development than biosynthetic pathways," says Sibley. "Taking out a biosynthetic pathway means you take away one thing from the parasite. But if you can successfully disable a key signal, this may potentially disrupt many more aspects of the parasite's metabolism."

Kisaburo Nagamune, Ph.D., formerly a postdoctoral fellow in Sibley's laboratory, found the ABA pathway in T. gondii while searching the parasite's genome for pathways linked to calcium signalling. Researchers knew that calcium signaling was important to the parasite's ability to control its complex reproductive cycle, but a search for genes similar to the calcium signaling pathways found in mammalian cells, such as the calcium receptors or channels that are common in heart cells and neurons, found few analogs in T. gondii.

ABA has many prominent roles in plant biology, including regulation of flowering and seed dormancy. A series of experiments led by Nagamune, now an assistant professor at Tsukuba University in Japan, showed that ABA helps the parasites control their reproductive cycle by communicating with each other in the host cell. When they sense high enough levels of ABA, the parasites break out of host cells; otherwise, they stay in the host cell and remain dormant.

With help of online databases and botanists at the Donald Danforth Plant Science Center in St. Louis and elsewhere, researchers quickly identified a class of herbicides that block ABA production and that are already in use commercially and screened for low toxicity to animals.

Scientists tested one of those herbicides against toxoplasmosis, labeling the test parasites with the firefly luciferase protein. Whole animal imaging showed that treatment with the herbicide reduced the number of parasites in infected mice during the initial infection and also reduced the chronic burden.

Sibley plans further studies to learn what other aspects of T. gondii biology are controlled by ABA and whether other inhibitors of ABA might make more potent treatments for toxoplasmosis. Nagamune is exploring the new findings' implications for treatment of malaria.


'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert

Related biology news :

1. Risk of common vaginal infection linked to preterm birth appears higher for blacks
2. Features of replication suggest viruses have common themes, vulnerabilities
3. Genetics determine optimal drug dose of common anticoagulant
4. All eukaryotic kinases share 1 common set of substrates
5. 60 second test could help early diagnosis of common brain diseases
6. Soy isoflavone may inhibit common gastrointestinal illness in infants
7. The importance of gene regulation for common human disease
8. Genes and environment grant funds close look at nature-nurture overlap in common diseases
9. Thriving hybrid salamanders contradict common wisdom
10. UCI researchers restore memory process in most common form of mental disability
11. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... 16, 2017  This year,s edition of the Inc. 5000 features a ... workforce solutions, has made the list for the third year in a ... fastest-growing private companies based on a set of quantitative metrics. In addition, ... fastest-growing companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical Diagnostics ... biotherapeutics development, announces the launch of the new NHS Agile biosensor chip ... binding data for a wide range of molecules, including small and large molecules, ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... The ... time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. ... February 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our ...
(Date:8/14/2017)... ... August 14, 2017 , ... ... interconnect using USB or PCI Express, announced the release of SYZYGY™, a new ... to satisfy the need for a compact, low cost, low pin-count, high-performance connectivity ...
Breaking Biology Technology: